{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:57:00Z","timestamp":1759683420592,"version":"3.40.5"},"reference-count":117,"publisher":"Bentham Science Publishers Ltd.","issue":"37","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,11,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>N-acetyl-cysteine (NAC) has shown widespread utility in different psychiatric disorders, including a beneficial role in schizophrenic patients. Although the replenishment of glutathione and the antioxidant activity of NAC have been suggested as the mechanisms that improve such a wide range of disorders, no one seems to be sufficiently specific to explain these intriguing effects. A sensitive cysteine proteome is emerging as a functional and structural network of interconnected sensitive cysteine-containing proteins (SCCPs) that together with reactive species and the cysteine\/glutathione cycles can regulate the bioenergetic metabolism, the redox homeostasis and the cellular growth, differentiation and survival, acting through different pathways that are regulated by the same thiol radical in cysteine residues.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Since this sensitive cysteine network has been implicated in the pathogenesis of Parkinson and Alzheimer\u00b4s diseases, I have reviewed if the proteins that play a role in schizophrenia can be classified too as SCCPs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> I have revised the major proteins implicated in the physiopathology of schizophrenia searching for those proteins that are redox-regulated through sensitive cysteine thiols. Results show that the principal proteins playing a role in schizophrenia can be classified as SCCPs, suggesting that the sensitive cysteine proteome (cysteinet) is defective in this type of psychosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The present review proposes that there is a deregulation of the sensitive cysteine proteome in schizophrenia as the consequence of a functional imbalance among different SCCPs, which play different functions in neurons and glial cells. In this context, the role of NAC to restore and prevent schizophrenic disorders is discussed.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666191015091346","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T15:07:41Z","timestamp":1585840061000},"page":"6424-6439","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["N-acetyl-cysteine in Schizophrenia: Potential Role on the Sensitive Cysteine Proteome"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-7205","authenticated-orcid":true,"given":"Marcos","family":"Mart\u00ednez-Banaclocha","sequence":"first","affiliation":[{"name":"Pathology Service, Lluis Alcanyis Hospital, Carretera Xativa-Silla Km2; 46800 X\u00e1tiva, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"Saha S.","year":"2005","unstructured":"Saha S.; Chant D.; Welham J.; McGrath J.; A systematic review of the prevalence of schizophrenia. PLoS Med 2005,2(5)","journal-title":"PLoS Med"},{"key":"ref=2","first-page":"415","volume":"28","author":"Berry N.","year":"2003","unstructured":"Berry N.; Jobanputra V.; Pal H.; Molecular genetics of schizophrenia: a critical review. J Psychiatry Neurosci 2003,28(6),415-429","journal-title":"J Psychiatry Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000488679","volume":"4","author":"Avramopoulos D.","year":"2018","unstructured":"Avramopoulos D.; Recent advances in the genetics of schizophrenia. Mol Neuropsychiatry 2018,4(1),35-51","journal-title":"Mol Neuropsychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.neubiorev.2011.12.015","volume":"36","author":"Shepherd A.M.","year":"2012","unstructured":"Shepherd A.M.; Laurens K.R.; Matheson S.L.; Carr V.J.; Green M.J.; Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012,36(4),1342-1356","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/sjop.12414","volume":"59","author":"Rund B.R.","year":"2018","unstructured":"Rund B.R.; The research evidence for schizophrenia as a neurodevelopmental disorder. Scand J Psychol 2018,59(1),49-58","journal-title":"Scand J Psychol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"Rapoport J.L.","year":"2012","unstructured":"Rapoport J.L.; Giedd J.N.; Gogtay N.; Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012,17(12),1228-1238","journal-title":"Mol Psychiatry"},{"key":"ref=7","first-page":"638","volume":"39","author":"Patel K.R.","year":"2014","unstructured":"Patel K.R.; Cherian J.; Gohil K.; Atkinson D.; Schizophrenia: overview and treatment options. P 2014,39(9),638-645","journal-title":"P"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/jamapsychiatry.2013.3469","volume":"71","author":"Baker J.T.","year":"2014","unstructured":"Baker J.T.; Holmes A.J.; Masters G.A.; Yeo B.T.; Krienen F.; Buckner R.L.; \u00d6ng\u00fcr D.; Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry 2014,71(2),109-118","journal-title":"JAMA Psychiatry"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/brain\/awy133","volume":"141","author":"Schifani C.","year":"2018","unstructured":"Schifani C.; Tseng H-H.; Kenk M.; Tagore A.; Kiang M.; Wilson A.A.; Houle S.; Rusjan P.M.; Mizrahi R.; Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis. Brain 2018,141(7),2213-2224","journal-title":"Brain"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biopsych.2010.08.022","volume":"69","author":"Zalesky A.","year":"2011","unstructured":"Zalesky A.; Fornito A.; Seal M.L.; Cocchi L.; Westin C.F.; Bullmore E.T.; Egan G.F.; Pantelis C.; Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry 2011,69(1),80-89","journal-title":"Biol Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fncel.2016.00018","volume":"10","author":"Davalieva K.","year":"2016","unstructured":"Davalieva K.; Maleva Kostovska I.; Dwork A.J.; Proteomics research in schizophrenia. Front Cell Neurosci 2016,10,18","journal-title":"Front Cell Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"14003","DOI":"10.1038\/npjschz.2014.3","volume":"1","author":"Nascimento J.M.","year":"2015","unstructured":"Nascimento J.M.; Martins-de-Souza D.; The proteome of schizophrenia. NPJ Schizophr 2015,1,14003","journal-title":"NPJ Schizophr"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/acps.12862","volume":"137","author":"Zheng W.","year":"2018","unstructured":"Zheng W.; Zhang Q.E.; Cai D.B.; Yang X.H.; Qiu Y.; Ungvari G.S.; Ng C.H.; Berk M.; Ning Y.P.; Xiang Y.T.; N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Acta Psychiatr Scand 2018,137(5),391-400","journal-title":"Acta Psychiatr Scand"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2469486","volume":"2018","author":"Ooi S.L.","year":"2018","unstructured":"Ooi S.L.; Green R.; Pak S.C.; N-Acetylcysteine for the treatment of psychiatric disorders: a review of current evidence. BioMed Res Int 2018,2018","journal-title":"BioMed Res Int"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"Dean O.","year":"2011","unstructured":"Dean O.; Giorlando F.; Berk M.; N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011,36(2),78-86","journal-title":"J Psychiatry Neurosci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12888-016-1030-3","volume":"16","author":"Rossell S.L.","year":"2016","unstructured":"Rossell S.L.; Francis P.S.; Galletly C.; Harris A.; Siskind D.; Berk M.; Bozaoglu K.; Dark F.; Dean O.; Liu D.; Meyer D.; Neill E.; Phillipou A.; Sarris J.; Castle D.J.; N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry 2016,16(1),320","journal-title":"BMC Psychiatry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","volume":"55","author":"Deepmala D.","year":"2015","unstructured":"Deepmala D.; Slattery J.; Kumar N.; Delhey L.; Berk M.; Dean O.; Spielholz C.; Frye R.; Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev 2015,55,294-321","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/9781681081892116020004","volume":"2","author":"Martinez-Banaclocha M.","year":"2016","unstructured":"Martinez-Banaclocha M.;  2016,2,105-172"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2174\/092986610791306760","volume":"17","author":"Mollica A.","year":"2010","unstructured":"Mollica A.; Feliciani F.; Stefanucci A.; Cacciatore I.; Cornacchia C.; Torino D.; Pinnen F.N.; -(tert)-butyloxycarbonyl)-beta,beta-cyclopentyl-cysteine (acetamidomethyl)-methyl ester for synthesis of novel peptidomimetic derivatives. Protein Pept Lett 2010,17(7),925-929","journal-title":"Protein Pept Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/138955712798868995","volume":"12","author":"Cacciatore I.","year":"2012","unstructured":"Cacciatore I.; Cornacchia C.; Baldassarre L.; Fornasari E.; Mollica A.; Stefanucci A.; Pinnen F.; GPE and GPE analogues as promising neuroprotective agents. Mini Rev Med Chem 2012,12(1),13-23","journal-title":"Mini Rev Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1573407212666160511162915","volume":"12","author":"Stefanucci A.","year":"2016","unstructured":"Stefanucci A.; Costante R.; Macedonio G.; Cysteine-, methionine- and seleno-cysteine-proline chimeras: synthesis and their use in peptidomimetics design. Curr Bioact Compd 2016,12,200","journal-title":"Curr Bioact Compd"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"26512","DOI":"10.1074\/jbc.R113.464131","volume":"288","author":"Go Y-M.","year":"2013","unstructured":"Go Y-M.; Jones D.P.; The redox proteome. J Biol Chem 2013,288(37),26512-26520","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/INDJ\/2018\/44483","volume":"12","author":"Martinez-Banaclocha M.","year":"2018","unstructured":"Martinez-Banaclocha M.; N-acetylcysteine in psychiatric disorders: possible role of cysteinet deregulation. Inter Neuropsy Dis J 2018,12,1-6","journal-title":"Inter Neuropsy Dis J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/1389200217666151210125918","volume":"17","author":"Mart\u00ednez-Banaclocha M.","year":"2016","unstructured":"Mart\u00ednez-Banaclocha M.; Cysteine network (CYSTEINET) dysregulation in Parkinson\u2019s disease: role of N-acetylcysteine. Curr Drug Metab 2016,17(4),368-385","journal-title":"Curr Drug Metab"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.36959\/734\/367","volume":"1","author":"Martinez-Banaclocha M.","year":"2016","unstructured":"Martinez-Banaclocha M.; N-acetylcysteine: A natural antidote for Alzheimer\u2019s disease. Alzheimer Dis Dement 2016,1,4-15","journal-title":"Alzheimer Dis Dement"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"E7978","DOI":"10.1073\/pnas.1807918115","volume":"115","author":"Petrova B.","year":"2018","unstructured":"Petrova B.; Liu K.; Tian C.; Kitaoka M.; Freinkman E.; Yang J.; Orr-Weaver T.L.; Dynamic redox balance directs the oocyte-to-embryo transition via developmentally controlled reactive cysteine changes. Proc Natl Acad Sci USA 2018,115(34),E7978-E7986","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/bj1170291","volume":"117","author":"Anderson P.J.","year":"1970","unstructured":"Anderson P.J.; Perham R.N.; The reactivity of thiol groups and the subunit structure of aldolase. Biochem J 1970,117(2),291-298","journal-title":"Biochem J"},{"key":"ref=28","author":"Voet D.","year":"2008","unstructured":"Voet D.; Voet J.; Pratt C.;  Fundamentals of biochemistry 2008","journal-title":"Fundamentals of biochemistry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/0929867323666161129124549","volume":"24","author":"Mart\u00ednez-Banaclocha M.A.","year":"2017","unstructured":"Mart\u00ednez-Banaclocha M.A.; Cysteinet dysregulation in muscular dystrophies: a pathogenic network susceptible to therapy. Curr Med Chem 2017,24(3),312-330","journal-title":"Curr Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2010-1375","volume":"20","author":"Butterfield D.A.","year":"2010","unstructured":"Butterfield D.A.; Hardas S.S.; Lange M.L.; Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer\u2019s disease: many pathways to neurodegeneration. J Alzheimers Dis 2010,20(2),369-393","journal-title":"J Alzheimers Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.redox.2013.12.011","volume":"2","author":"Mailloux R.J.","year":"2013","unstructured":"Mailloux R.J.; Jin X.; Willmore W.G.; Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol 2013,2,123-139","journal-title":"Redox Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1073\/pnas.0501519102","volume":"102","author":"Bulteau A.L.","year":"2005","unstructured":"Bulteau A.L.; Lundberg K.C.; Ikeda-Saito M.; Isaya G.; Szweda L.I.; Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia\/reperfusion. Proc Natl Acad Sci USA 2005,102(17),5987-5991","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"22353","DOI":"10.1016\/S0021-9258(18)41535-9","volume":"268","author":"Ali M.S.","year":"1993","unstructured":"Ali M.S.; Roche T.E.; Patel M.S.; Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase. J Biol Chem 1993,268(30),22353-22356","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0006-8993(99)02349-5","volume":"855","author":"Mart\u00ednez M.","year":"2000","unstructured":"Mart\u00ednez M.; Hern\u00e1ndez A.I.; Mart\u00ednez N.; N-Acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria. Brain Res 2000,855(1),100-106","journal-title":"Brain Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0006-8993(00)02005-9","volume":"859","author":"Mart\u00ednez Banaclocha M.","year":"2000","unstructured":"Mart\u00ednez Banaclocha M.; N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson\u2019s disease. Brain Res 2000,859(1),173-175","journal-title":"Brain Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0006-8993(99)01819-3","volume":"842","author":"Mart\u00ednez Banaclocha M.","year":"1999","unstructured":"Mart\u00ednez Banaclocha M.; Mart\u00ednez N.; N-acetylcysteine elicited increase in cytochrome c oxidase activity in mice synaptic mitochondria. Brain Res 1999,842(1),249-251","journal-title":"Brain Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0006-8993(97)00493-9","volume":"762","author":"Banaclocha M.M.","year":"1997","unstructured":"Banaclocha M.M.; Hern\u00e1ndez A.I.; Mart\u00ednez N.; Ferr\u00e1ndiz M.L.; N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria. Brain Res 1997,762(1-2),256-258","journal-title":"Brain Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1054\/mehy.2000.1194","volume":"56","author":"Banaclocha M.M.","year":"2001","unstructured":"Banaclocha M.M.; Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases. Med Hypotheses 2001,56(4),472-477","journal-title":"Med Hypotheses"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCRESAHA.111.246124","volume":"109","author":"Wang S.B.","year":"2011","unstructured":"Wang S.B.; Foster D.B.; Rucker J.; O\u2019Rourke B.; Kass D.A.; Van Eyk J.E.; Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res 2011,109(7),750-757","journal-title":"Circ Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"47939","DOI":"10.1074\/jbc.M408011200","volume":"279","author":"Beer S.M.","year":"2004","unstructured":"Beer S.M.; Taylor E.R.; Brown S.E.; Dahm C.C.; Costa N.J.; Runswick M.J.; Murphy M.P.; Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 2004,279(46),47939-47951","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.yjmcc.2018.07.244","volume":"121","author":"Kang P.T.","year":"2018","unstructured":"Kang P.T.; Chen C.L.; Lin P.; Zhang L.; Zweier J.L.; Chen Y.R.; Mitochondrial complex I in the post-ischemic heart: reperfusion-mediated oxidative injury and protein cysteine sulfonation. J Mol Cell Cardiol 2018,121,190-204","journal-title":"J Mol Cell Cardiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1074\/jbc.M110.190108","volume":"286","author":"Danielson S.R.","year":"2011","unstructured":"Danielson S.R.; Held J.M.; Oo M.; Riley R.; Gibson B.W.; Andersen J.K.; Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model. J Biol Chem 2011,286(9),7601-7608","journal-title":"J Biol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2527\/jas.2009-2381","volume":"88","author":"Guttmann R.P.","year":"2010","unstructured":"Guttmann R.P.; Redox regulation of cysteine-dependent enzymes. J Anim Sci 2010,88(4),1297-1306","journal-title":"J Anim Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"Liesa M.","year":"2013","unstructured":"Liesa M.; Shirihai O.S.; Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 2013,17(4),491-506","journal-title":"Cell Metab"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","volume":"125","author":"Chan D.C.","year":"2006","unstructured":"Chan D.C.; Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006,125(7),1241-1252","journal-title":"Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/embor.2012.128","volume":"13","author":"Shutt T.","year":"2012","unstructured":"Shutt T.; Geoffrion M.; Milne R.; McBride H.M.; The intracellular redox state is a core determinant of mitochondrial fusion. EMBO Rep 2012,13(10),909-915","journal-title":"EMBO Rep"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069165","volume":"8","author":"Redpath C.J.","year":"2013","unstructured":"Redpath C.J.; Bou Khalil M.; Drozdzal G.; Radisic M.; McBride H.M.; Mitochondrial hyperfusion during oxidative stress is coupled to a dysregulation in calcium handling within a C2C12 cell model. PLoS One 2013,8(7)","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1083\/jcb.201611194","volume":"217","author":"Mattie S.","year":"2018","unstructured":"Mattie S.; Riemer J.; Wideman J.G.; McBride H.M.; A new mitofusin topology places the redox-regulated C terminus in the mitochondrial intermembrane space. J Cell Biol 2018,217(2),507-515","journal-title":"J Cell Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuint.2017.05.009","volume":"117","author":"Thaher O.","year":"2018","unstructured":"Thaher O.; Wolf C.; Dey P.N.; Pouya A.; W\u00fcllner V.; Tenzer S.; Methner A.; The thiol switch C684 in Mitofusin-2 mediates redox-induced alterations of mitochondrial shape and respiration. Neurochem Int 2018,117,167-173","journal-title":"Neurochem Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.schres.2017.05.003","volume":"187","author":"Flippo K.H.","year":"2017","unstructured":"Flippo K.H.; Strack S.; An emerging role for mitochondrial dynamics in schizophrenia. Schizophr Res 2017,187,26-32","journal-title":"Schizophr Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/cdd.2011.65","volume":"18","author":"Nakamura T.","year":"2011","unstructured":"Nakamura T.; Lipton S.A.; Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 2011,18(9),1478-1486","journal-title":"Cell Death Differ"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuropharm.2011.01.049","volume":"62","author":"Powell S.B.","year":"2012","unstructured":"Powell S.B.; Sejnowski T.J.; Behrens M.M.; Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 2012,62(3),1322-1331","journal-title":"Neuropharmacology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","volume":"73","author":"Cabungcal J.H.","year":"2013","unstructured":"Cabungcal J.H.; Steullet P.; Kraftsik R.; Cuenod M.; Do K.Q.; Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol Psychiatry 2013,73(6),574-582","journal-title":"Biol Psychiatry"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/sj.emboj.7600276","volume":"23","author":"Furukawa Y.","year":"2004","unstructured":"Furukawa Y.; Torres A.S.; O\u2019Halloran T.V.; Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 2004,23(14),2872-2881","journal-title":"EMBO J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1074\/jbc.M500482200","volume":"280","author":"Furukawa Y.","year":"2005","unstructured":"Furukawa Y.; O\u2019Halloran T.V.; Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem 2005,280(17),17266-17274","journal-title":"J Biol Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"24167","DOI":"10.1074\/jbc.M802083200","volume":"283","author":"Furukawa Y.","year":"2008","unstructured":"Furukawa Y.; Kaneko K.; Yamanaka K.; O\u2019Halloran T.V.; Nukina N.; Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J Biol Chem 2008,283(35),24167-24176","journal-title":"J Biol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1074\/jbc.M705657200","volume":"283","author":"Cozzolino M.","year":"2008","unstructured":"Cozzolino M.; Amori I.; Pesaresi M.G.; Ferri A.; Nencini M.; Carr\u00ec M.T.; Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem 2008,283(2),866-874","journal-title":"J Biol Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.bbrc.2015.06.084","volume":"463","author":"Ogawa M.","year":"2015","unstructured":"Ogawa M.; Shidara H.; Oka K.; Kurosawa M.; Nukina N.; Furukawa Y.; Cysteine residues in Cu,Zn-superoxide dismutase are essential to toxicity in Caenorhabditis elegans model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2015,463(4),1196-1202","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1074\/jbc.M112.414235","volume":"288","author":"Toichi K.","year":"2013","unstructured":"Toichi K.; Yamanaka K.; Furukawa Y.; Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. J Biol Chem 2013,288(7),4970-4980","journal-title":"J Biol Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14348\/molcells.2016.2368","volume":"39","author":"Rhee S.G.","year":"2016","unstructured":"Rhee S.G.; Overview on Peroxiredoxin. Mol Cells 2016,39(1),1-5","journal-title":"Mol Cells"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"Gysin R.","year":"2007","unstructured":"Gysin R.; Kraftsik R.; Sandell J.; Bovet P.; Chappuis C.; Conus P.; Deppen P.; Preisig M.; Ruiz V.; Steullet P.; Tosic M.; Werge T.; Cu\u00e9nod M.; Do K.Q.; Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA 2007,104(42),16621-16626","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/507566","volume":"79","author":"Tosic M.","year":"2006","unstructured":"Tosic M.; Ott J.; Barral S.; Bovet P.; Deppen P.; Gheorghita F.; Matthey M.L.; Parnas J.; Preisig M.; Saraga M.; Solida A.; Timm S.; Wang A.G.; Werge T.; Cu\u00e9nod M.; Do K.Q.; Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006,79(3),586-592","journal-title":"Am J Hum Genet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/mp.2009.53","volume":"15","author":"Rodr\u00edguez-Santiago B.","year":"2010","unstructured":"Rodr\u00edguez-Santiago B.; Brunet A.; Sobrino B.; Serra-Juh\u00e9 C.; Flores R.; Armengol L.; Vilella E.; Gabau E.; Guitart M.; Guillamat R.; Martorell L.; Valero J.; Guti\u00e9rrez-Zotes A.; Labad A.; Carracedo A.; Estivill X.; P\u00e9rez-Jurado L.A.; Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia. Mol Psychiatry 2010,15(10),1023-1033","journal-title":"Mol Psychiatry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/schbul\/sbu048","volume":"40","author":"O\u2019Donnell P.","year":"2014","unstructured":"O\u2019Donnell P.; Do K.Q.; Arango C.; Oxidative\/Nitrosative stress in psychiatric disorders: are we there yet? Schizophr Bull 2014,40(5),960-962","journal-title":"Schizophr Bull"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/bj3210207","volume":"321","author":"Gali R.R.","year":"1997","unstructured":"Gali R.R.; Board P.G.; Identification of an essential cysteine residue in human glutathione synthase. Biochem J 1997,321(Pt 1),207-210","journal-title":"Biochem J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3600001","volume":"360","author":"Sheehan D.","year":"2001","unstructured":"Sheehan D.; Meade G.; Foley V.M.; Dowd C.A.; Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001,360(Pt 1),1-16","journal-title":"Biochem J"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1573400054065569","volume":"1","author":"Kenji H.","year":"2005","unstructured":"Kenji H.; Eiji S.; Masaomi I.; Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiatry Rev 2005,1,151-163","journal-title":"Curr Psychiatry Rev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jmb.2007.04.056","volume":"370","author":"Lassing I.","year":"2007","unstructured":"Lassing I.; Schmitzberger F.; Bj\u00f6rnstedt M.; Holmgren A.; Nordlund P.; Schutt C.E.; Lindberg U.; Molecular and structural basis for redox regulation of \u03b2-actin. J Mol Biol 2007,370(2),331-348","journal-title":"J Mol Biol"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/514847","volume":"2012","author":"McDonagh B.","year":"2012","unstructured":"McDonagh B.; Mart\u00ednez-Acedo P.; V\u00e1zquez J.; Padilla C.A.; Sheehan D.; B\u00e1rcena J.A.; Application of iTRAQ reagents to relatively quantify the reversible redox state of cysteine residues. Int J Proteomics 2012,2012","journal-title":"Int J Proteomics"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1083\/jcb.100.3.843","volume":"100","author":"Lewis S.A.","year":"1985","unstructured":"Lewis S.A.; Cowan N.J.; Genetics, evolution, and expression of the 68,000-mol-wt neurofilament protein: isolation of a cloned cDNA probe. J Cell Biol 1985,100(3),843-850","journal-title":"J Cell Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0378-1119(88)90033-9","volume":"68","author":"Julien J-P.","year":"1988","unstructured":"Julien J-P.; C\u00f4t\u00e9 F.; Beaudet L.; Sidky M.; Flavell D.; Grosveld F.; Mushynski W.; Sequence and structure of the mouse gene coding for the largest neurofilament subunit. Gene 1988,68(2),307-314","journal-title":"Gene"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1083\/jcb.127.1.173","volume":"127","author":"Takeda S.","year":"1994","unstructured":"Takeda S.; Okabe S.; Funakoshi T.; Hirokawa N.; Differential dynamics of neurofilament-H protein and neurofilament-L protein in neurons. J Cell Biol 1994,127(1),173-185","journal-title":"J Cell Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"Purcell S.M.","year":"2009","unstructured":"Purcell S.M.; Wray N.R.; Stone J.L.; Visscher P.M.; O\u2019Donovan M.C.; Sullivan P.F.; Sklar P.; Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature International Schizophrenia Consortium2009,460(7256),748-752","journal-title":"Nature"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.0500515102","volume":"102","author":"Callicott J.H.","year":"2005","unstructured":"Callicott J.H.; Straub R.E.; Pezawas L.; Egan M.F.; Mattay V.S.; Hariri A.R.; Verchinski B.A.; Meyer-Lindenberg A.; Balkissoon R.; Kolachana B.; Goldberg T.E.; Weinberger D.R.; Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005,102(24),8627-8632","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pscychresns.2009.01.005","volume":"172","author":"Takahashi T.","year":"2009","unstructured":"Takahashi T.; Suzuki M.; Tsunoda M.; Maeno N.; Kawasaki Y.; Zhou S.Y.; Hagino H.; Niu L.; Tsuneki H.; Kobayashi S.; Sasaoka T.; Seto H.; Kurachi M.; Ozaki N.; The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. Psychiatry Res 2009,172(2),128-135","journal-title":"Psychiatry Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pnpbp.2014.07.005","volume":"56","author":"Takahashi T.","year":"2015","unstructured":"Takahashi T.; Nakamura M.; Nakamura Y.; Aleksic B.; Kido M.; Sasabayashi D.; Takayanagi Y.; Furuichi A.; Nishikawa Y.; Noguchi K.; Ozaki N.; Suzuki M.; The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain neurodevelopmental markers in schizophrenia and healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 2015,56,11-17","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/cercor\/bhs167","volume":"23","author":"Li Y.","year":"2013","unstructured":"Li Y.; Liu B.; Hou B.; Qin W.; Wang D.; Yu C.; Jiang T.; Less efficient information transfer in Cys-allele carriers of DISC1: a brain network study based on diffusion MRI. Cereb Cortex 2013,23(7),1715-1723","journal-title":"Cereb Cortex"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1124\/jpet.116.237503","volume":"360","author":"Salim S.","year":"2017","unstructured":"Salim S.; Oxidative stress and the central nervous system. J Pharmacol Exp Ther 2017,360(1),201-205","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.freeradbiomed.2018.04.007","volume":"120","author":"Viedma-Poyatos \u00c1.","year":"2018","unstructured":"Viedma-Poyatos \u00c1.; de Pablo Y.; Pekny M.; P\u00e9rez-Sala D.; The cysteine residue of glial fibrillary acidic protein is a critical target for lipoxidation and required for efficient network organization. Free Radic Biol Med 2018,120,380-394","journal-title":"Free Radic Biol Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"35117","DOI":"10.1074\/jbc.M113.521443","volume":"288","author":"Gellert M.","year":"2013","unstructured":"Gellert M.; Venz S.; Mitl\u00f6hner J.; Cott C.; Hanschmann E.M.; Lillig C.H.; Identification of a dithiol-disulfide switch in collapsin response mediator protein 2 (CRMP2) that is toggled in a model of neuronal differentiation. J Biol Chem 2013,288(49),35117-35125","journal-title":"J Biol Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/gbb.12193","volume":"14","author":"Freudenberg F.","year":"2015","unstructured":"Freudenberg F.; Alttoa A.; Reif A.; Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav 2015,14(1),46-63","journal-title":"Genes Brain Behav"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"34799","DOI":"10.1074\/jbc.273.52.34799","volume":"273","author":"Mart\u00e1sek P.","year":"1998","unstructured":"Mart\u00e1sek P.; Miller R.T.; Liu Q.; Roman L.J.; Salerno J.C.; Migita C.T.; Raman C.S.; Gross S.S.; Ikeda-Saito M.; Masters B.S.; The C331A mutant of neuronal nitric-oxide synthase is defective in arginine binding. J Biol Chem 1998,273(52),34799-34805","journal-title":"J Biol Chem"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.5772\/67494","author":"Arami K.M.","year":"2017","unstructured":"Arami K.M.; Jameie B.; Moosavi S.A.;  Neuronal nitric oxide synthase 2017","journal-title":"Neuronal nitric oxide synthase"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1073\/pnas.0600729103","volume":"103","author":"Greco T.M.","year":"2006","unstructured":"Greco T.M.; Hodara R.; Parastatidis I.; Heijnen H.F.; Dennehy M.K.; Liebler D.C.; Ischiropoulos H.; Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci USA 2006,103(19),7420-7425","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1073\/pnas.0508412103","volume":"103","author":"Hao G.","year":"2006","unstructured":"Hao G.; Derakhshan B.; Shi L.; Campagne F.; Gross S.S.; SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci USA 2006,103(4),1012-1017","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1021\/cr300163e","volume":"113","author":"Paulsen C.E.","year":"2013","unstructured":"Paulsen C.E.; Carroll K.S.; Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev 2013,113(7),4633-4679","journal-title":"Chem Rev"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/24790","volume":"396","author":"Migaud M.","year":"1998","unstructured":"Migaud M.; Charlesworth P.; Dempster M.; Webster L.C.; Watabe A.M.; Makhinson M.; He Y.; Ramsay M.F.; Morris R.G.; Morrison J.H.; O\u2019Dell T.J.; Grant S.G.; Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998,396(6710),433-439","journal-title":"Nature"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1021\/bi7008618","volume":"46","author":"Jemth P.","year":"2007","unstructured":"Jemth P.; Gianni S.; PDZ domains: folding and binding. Biochemistry 2007,46(30),8701-8708","journal-title":"Biochemistry"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biopsych.2014.10.016","volume":"77","author":"Carrel D.","year":"2015","unstructured":"Carrel D.; Hernandez K.; Kwon M.; Mau C.; Trivedi M.P.; Brzustowicz L.M.; Firestein B.L.; Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons. Biol Psychiatry 2015,77(11),969-978","journal-title":"Biol Psychiatry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuron.2011.05.033","volume":"71","author":"Ho G.P.","year":"2011","unstructured":"Ho G.P.; Selvakumar B.; Mukai J.; Hester L.D.; Wang Y.; Gogos J.A.; Snyder S.H.; S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 2011,71(1),131-141","journal-title":"Neuron"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuron.2006.07.011","volume":"51","author":"Cheah J.H.","year":"2006","unstructured":"Cheah J.H.; Kim S.F.; Hester L.D.; Clancy K.W.; Patterson S.E.; Papadopoulos V.; Snyder S.H.; NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 2006,51(4),431-440","journal-title":"Neuron"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.1523\/JNEUROSCI.5287-08.2009","volume":"29","author":"Carrel D.","year":"2009","unstructured":"Carrel D.; Du Y.; Komlos D.; Hadzimichalis N.M.; Kwon M.; Wang B.; Brzustowicz L.M.; Firestein B.L.; NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 2009,29(25),8248-8258","journal-title":"J Neurosci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fncel.2016.00006","volume":"10","author":"Hernandez K.","year":"2016","unstructured":"Hernandez K.; Swiatkowski P.; Patel M.V.; Liang C.; Dudzinski N.R.; Brzustowicz L.M.; Firestein B.L.; Overexpression of isoforms of nitric oxide synthase 1 adaptor protein, encoded by a risk gene for schizophrenia, alters actin dynamics and synaptic function. Front Cell Neurosci 2016,10,6","journal-title":"Front Cell Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biopsych.2006.01.019","volume":"60","author":"Detera-Wadleigh S.D.","year":"2006","unstructured":"Detera-Wadleigh S.D.; McMahon F.J.; G72\/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006,60(2),106-114","journal-title":"Biol Psychiatry"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.74","volume":"6","author":"P\u00f3sfai B.","year":"2016","unstructured":"P\u00f3sfai B.; Cser\u00e9p C.; Heged\u00fcs P.; Szabadits E.; Otte D.M.; Zimmer A.; Watanabe M.; Freund T.F.; Nyiri G.; Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment. Transl Psychiatry 2016,6(5)","journal-title":"Transl Psychiatry"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/npp.2011.109","volume":"36","author":"Otte D.M.","year":"2011","unstructured":"Otte D.M.; Sommersberg B.; Kudin A.; Guerrero C.; Albayram O.; Filiou M.D.; Frisch P.; Yilmaz O.; Drews E.; Turck C.W.; Bilkei-Gorz\u00f3 A.; Kunz W.S.; Beck H.; Zimmer A.; N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72\/G30 transgenic mice. Neuropsychopharmacology 2011,36(11),2233-2243","journal-title":"Neuropsychopharmacology"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10571-014-0087-0","volume":"34","author":"Otte D.M.","year":"2014","unstructured":"Otte D.M.; Rask\u00f3 T.; Wang M.; Dreiseidler M.; Drews E.; Schrage H.; Wojtalla A.; H\u00f6hfeld J.; Wanker E.; Zimmer A.; Identification of the mitochondrial MSRB2 as a binding partner of LG72. Cell Mol Neurobiol 2014,34(8),1123-1130","journal-title":"Cell Mol Neurobiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0140-6736(94)91581-4","volume":"343","author":"Arinami T.","year":"1994","unstructured":"Arinami T.; Itokawa M.; Enguchi H.; Tagaya H.; Yano S.; Shimizu H.; Hamaguchi H.; Toru M.; Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994,343(8899),703-704","journal-title":"Lancet"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1440-1819.1997.tb02603.x","volume":"51","author":"Kaneshima M.","year":"1997","unstructured":"Kaneshima M.; Higa T.; Nakamoto H.; Nagamine M.; An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin Neurosci 1997,51(6),379-381","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0165-1781(98)00125-5","volume":"85","author":"Tallerico T.","year":"1999","unstructured":"Tallerico T.; Ulpian C.; Liu I.S.; Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Psychiatry Res 1999,85(2),215-219","journal-title":"Psychiatry Res"},{"key":"ref=101","first-page":"161","volume":"43","author":"Serretti A.","year":"2000","unstructured":"Serretti A.; Lilli R.; Lorenzi C.; Smeraldi E.; Further evidence supporting the association between the dopamine receptor D2 Ser\/Cys311 variant and disorganized symptomatology of schizophrenia. Schizophr Res 2000,43(2-3),161-162","journal-title":"Schizophr Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.1998.tb10169.x","volume":"861","author":"G\u00f6thert M.","year":"1998","unstructured":"G\u00f6thert M.; Propping P.; B\u00f6nisch H.; Br\u00fcss M.; N\u00f6then M.M.; Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role. Ann N Y Acad Sci 1998,861,26-30","journal-title":"Ann N Y Acad Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"Howes O.","year":"2015","unstructured":"Howes O.; McCutcheon R.; Stone J.; Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (Oxford) 2015,29(2),97-115","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0165-6147(02)02060-6","volume":"23","author":"McBean G.J.","year":"2002","unstructured":"McBean G.J.; Cerebral cystine uptake: a tale of two transporters. Trends Pharmacol Sci 2002,23(7),299-302","journal-title":"Trends Pharmacol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","volume":"19","author":"Dringen R.","year":"1999","unstructured":"Dringen R.; Pfeiffer B.; Hamprecht B.; Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 1999,19(2),562-569","journal-title":"J Neurosci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","volume":"42","author":"Conrad M.","year":"2012","unstructured":"Conrad M.; Sato H.; The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 2012,42(1),231-246","journal-title":"Amino Acids"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1471-4159.1993.tb09802.x","volume":"61","author":"Sagara J.I.","year":"1993","unstructured":"Sagara J.I.; Miura K.; Bannai S.; Maintenance of neuronal glutathione by glial cells. J Neurochem 1993,61(5),1672-1676","journal-title":"J Neurochem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","volume":"27","author":"Banjac A.","year":"2008","unstructured":"Banjac A.; Perisic T.; Sato H.; Seiler A.; Bannai S.; Weiss N.; K\u00f6lle P.; Tschoep K.; Issels R.D.; Daniel P.T.; Conrad M.; Bornkamm G.W.; The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene 2008,27(11),1618-1628","journal-title":"Oncogene"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"Lewerenz J.","year":"2013","unstructured":"Lewerenz J.; Hewett S.J.; Huang Y.; Lambros M.; Gout P.W.; Kalivas P.W.; Massie A.; Smolders I.; Methner A.; Pergande M.; Smith S.B.; Ganapathy V.; Maher P.; The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 2013,18(5),522-555","journal-title":"Antioxid Redox Signal"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41398-018-0266-8","volume":"8","author":"Klauser P.","year":"2018","unstructured":"Klauser P.; Xin L.; Fournier M.; Griffa A.; Cleusix M.; Jenni R.; Cuenod M.; Gruetter R.; Hagmann P.; Conus P.; Baumann P.S.; Do K.Q.; N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial. Transl Psychiatry 2018,8(1),220","journal-title":"Transl Psychiatry"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/mol.117.109926","volume":"92","author":"Gleixner A.M.","year":"2017","unstructured":"Gleixner A.M.; Hutchison D.F.; Sannino S.; Bhatia T.N.; Leak L.C.; Flaherty P.T.; Wipf P.; Brodsky J.L.; Leak R.K.; N-acetyl-L-cysteine protects astrocytes against proteotoxicity without recourse to glutathione. Mol Pharmacol 2017,92(5),564-575","journal-title":"Mol Pharmacol"},{"key":"ref=112","first-page":"5","volume":"63","author":"Davidson M.","year":"2002","unstructured":"Davidson M.; Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry 2002,63(Suppl. 9),5-11","journal-title":"J Clin Psychiatry"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fpsyt.2014.00137","volume":"5","author":"Ringen P.A.","year":"2014","unstructured":"Ringen P.A.; Engh J.A.; Birkenaes A.B.; Dieset I.; Andreassen O.A.; Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry 2014,5,137","journal-title":"Front Psychiatry"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/thy.11.12","volume":"8","author":"Talasaz A.H.","year":"2011","unstructured":"Talasaz A.H.; Khalili H.; Fahimi F.; Potential role of N-acetylcisteine in cardiovascular disorders. Therapy 2011,8,237-245","journal-title":"Therapy"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12011-012-9320-1","volume":"147","author":"Ozcelik D.","year":"2012","unstructured":"Ozcelik D.; Uzun H.; Naz\u0131roglu M.; N-acetylcysteine attenuates copper overload-induced oxidative injury in brain of rat. Biol Trace Elem Res 2012,147(1-3),292-298","journal-title":"Biol Trace Elem Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1111\/jgh.14104","volume":"33","author":"Tarantino G.","year":"2018","unstructured":"Tarantino G.; Porcu C.; Arciello M.; Andreozzi P.; Balsano C.; Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability. J Gastroenterol Hepatol 2018,33(8),1511-1517","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0149-7634(82)90044-6","volume":"6","author":"Bowman M.B.","year":"1982","unstructured":"Bowman M.B.; Lewis M.S.; The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 1982,6(3),321-328","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/175664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/175664\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/175664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:23:14Z","timestamp":1621538594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/175664\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":117,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2020,11,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666191015091346","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}